DR. CHRISTINA HOPE YI, M.D.
Radiology at Parnassus Ave, San Francisco, CA
License number
California 4301099420
Category
Radiology
Type
Surgery
License number
California A147157
Category
Radiology
Type
Surgery
License number
California A147157
Category
Radiology
Type
Plastic and Reconstructive Surgery
Address
Address
2
400 Parnassus Ave, San Francisco, CA 94143
3320 Spinnaker Ln, Detroit, MI 48207
3320 Spinnaker Ln, Detroit, MI 48207
Phone
(415) 476-1000
(615) 568-4637
(615) 568-4637
Personal information
See more information about CHRISTINA HOPE YI at radaris.comName
Address
Phone
100 S Alameda St UNIT 157, Los Angeles, CA 90012
6211 Serena Pl, Alta Loma, CA 91737
540 S Fair Oaks Ave APT 1, Sunnyvale, CA 94086
415 Sanibelle Cir UNIT 76, Chula Vista, CA 91910
2501 Benvenue Ave APT 12, Berkeley, CA 94704
Professional information
Research Associate At Samsung Electronics Research Institute
Position:
Research Associate at Samsung Electronics Research Institute
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Samsung Electronics Research Institute
since May 2012
-
Research Associate
KaloBios
- South San Francisco Jul 2005 - Sep 2011
-
Senior Research Associate
Education:
University of California, Berkeley 1998 - 2002
Bachelors, Molecular Cell Biology, Cell Developmental Biology
Bachelors, Molecular Cell Biology, Cell Developmental Biology
Skills:
Antibodies, Protein Purification, Assay Development, Biochemistry, Drug Discovery, Flow Cytometry, HPLC, Molecular Biology, Protein Expression, Microscopy, Protein Chemistry, ELISA, PCR, Cell Culture, Immunohistochemistry, Cell, High Throughput Screening, Cell Biology, Molecular Cloning, Western Blotting, Biotechnology, Lifesciences
Research Associate At Samsung Electronics Research Institute
Position:
Research Associate at Samsung Electronics Research Institute
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Samsung Electronics Research Institute
since May 2012
-
Research Associate
KaloBios
- South San Francisco Jul 2005 - Sep 2011
-
Senior Research Associate
Education:
University of California, Berkeley 1998 - 2002
Bachelors, Molecular Cell Biology, Cell Developmental Biology
Bachelors, Molecular Cell Biology, Cell Developmental Biology
Skills:
Antibodies, Protein Purification, Assay Development, Biochemistry, Drug Discovery, Flow Cytometry, HPLC, Molecular Biology, Protein Expression, Microscopy, Protein Chemistry, ELISA, PCR, Cell Culture, Immunohistochemistry, Cell, High Throughput Screening, Cell Biology, Molecular Cloning, Western Blotting, Biotechnology, Lifesciences
Dr. Christina H Yi, Detroit MI - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
4201 Saint Antoine St, Detroit 48201
DETROIT RECEIVING HOSPITAL
4201 Saint Antoine St, Detroit 48201
(313) 745-3000 (Phone), (313) 577-8600 (Fax)
DETROIT RECEIVING HOSPITAL
4201 Saint Antoine St, Detroit 48201
(313) 745-3000 (Phone), (313) 577-8600 (Fax)
Languages:
English
Hospitals:
4201 Saint Antoine St, Detroit 48201
DETROIT RECEIVING HOSPITAL
4201 Saint Antoine St, Detroit 48201
Detroit Receiving Hospital
4201 St Antoine Blvd, Detroit 48201
DETROIT RECEIVING HOSPITAL
4201 Saint Antoine St, Detroit 48201
Detroit Receiving Hospital
4201 St Antoine Blvd, Detroit 48201
Education:
Medical School
Meharry Medical College
Graduated: 2011
Meharry Medical College
Graduated: 2011
Antibodies To Epha3
US Patent:
2011012, May 26, 2011
Filed:
Oct 14, 2010
Appl. No.:
12/904953
Inventors:
Kenneth Luehrsen - Half Moon Bay CA, US
David Martinez - Sunnyvale CA, US
Christina Yi - San Francisco CA, US
Christopher R. Bebbington - San Mateo CA, US
Geoffrey T. Yarranton - Burlingame CA, US
David Martinez - Sunnyvale CA, US
Christina Yi - San Francisco CA, US
Christopher R. Bebbington - San Mateo CA, US
Geoffrey T. Yarranton - Burlingame CA, US
Assignee:
KaloBios Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 39/395, C07K 16/28, A61P 35/00, A61P 35/02
US Classification:
4241721, 5303891
Abstract:
The current invention relates to high-affinity antibodies to EphA3 that have reduced immunogenicity when administered to a human to treat diseases and method of using such antibodies.